2016 Daily Conference News Headlines

May 17

  • ATS 2016 Draws Big CrowdsEarly attendance numbers show ATS 2016 in San Francisco, California, is a popular destination. As of Monday afternoon, there were more than 17,000 registered attendees from 90 countries. More
  • Ebola Fighter Catalyst for ChangeKatie Meyler will share the story of her compelling work as one of the “Ebola Fighters,” collectively recognized by TIME magazine as the 2014 Person of the Year, during the Plenary Session on Tuesday. At the onset of the largest Ebola epidemic in history, Ms. Meyler was spurred to turn her school for girls in Liberia into a disaster-response center. More
  • Keynote Series: COPD, GPCR Signaling, ARDS, AsthmaTuesday's Keynote Series presentations will examine chronic obstructive pulmonary disease (COPD) and G-protein coupled receptor (GPCR) signaling. Presenters on Wednesday will cover biomarkers for precision medicine in asthma and acute respiratory distress syndrome (ARDS). The lectures will be given concurrently from 8 to 8:45 a.m. More
  • Q&A: 2016-17 President-Elect David Gozal, MDAn interview with David Gozal, MD, ATS President-Elect. More
  • Companies Shine Patient Perspective on Lung DiseasesThree exhibitors will share unique ways in which they endeavor to raise awareness about devastating lung diseases. From the storytelling and artistry of patients, to a documentary film memorializing an actor, to a patient who ran in Bay to Breakers 2016 during the conference, the companies will show how these individuals are not defined by their lung disease diagnoses. More
  • Discoveries Offer Hope for Patients With PCDUntil recently, primary ciliary dyskinesia (PCD) has received little attention or research funding. More
  • COPD National Action PlanMore than 10 million Americans have diagnosed chronic obstructive pulmonary disease and another 10 million are living with undiagnosed COPD, according to estimates from the Centers for Disease Control and Prevention. More
  • 2016 ATS Assembly AwardsThe ATS presented several Assembly awards this year. View the list of award recipients. More
  • Mythbusters Challenge COPD TherapiesRecent studies are making many researchers re-evaluate long-standing ideas on the development of chronic obstructive pulmonary disease. An ATS mythbusters symposium on Wednesday will examine the emerging theory that the alteration of lung tissue regeneration, not inflammation, plays a driving role in the pathogenesis of COPD. More
  • ATS Weighs in on Clean Power LawsuitA battle over climate change is brewing in U.S. courts, and the ATS is fighting for the health of our patients. More
  • Managing IPF With Personalized TreatmentGreat progress has been made in the treatment of patients with idiopathic pulmonary fibrosis, but the use of molecular markers to implement precision medicine could revolutionize treatment in the near future. More
  • Get Free Access to SessionsExtend your ATS International Conference experience. Get one year of free complimentary access* to more than 200 hours of select ATS 2016 scientific symposia webcasts in the Best of ATS Conference collection. More
  • Stem Cells: Unveiling Their Promise for Lung DiseasesThe use of stem cells to prevent and treat human diseases has led to unprecedented growth in regenerative medicine. Increasing evidence has shown that an individual's own cells have the potential for development of stem cell-based therapeutic approaches. More
  • Burden of Respiratory Disease on MigrantsThe crisis in the Middle East has raised awareness about the challenges encountered by migrant populations, especially their access to health care. Migrant populations around the world, including those from Mexico and Latin America entering the United States, face similar challenges. More
  • ATS Welcomes Decision on Shorter MDR-TB RegimenOn May 12, the World Health Organization released recommendations aimed to speed up detection and improve treatment outcomes for multidrug resistant tuberculosis (MDR-TB) through the use of a novel, rapid diagnostic test and a shorter, cheaper treatment regimen. More
  • The ATS Center Shows Global ReachLearn about all that the American Thoracic Society has to offer, including its activities around the world, at the ATS Center in Booth 937 in the Exhibit Hall at Moscone Center, Halls A-C (South Building, Lower Level). Be sure to visit from 8 a.m. to 2:45 p.m. on Tuesday. More
  • Forums Celebrate Diversity and InclusivityTwo popular forums gave attendees the opportunity to recognize and support diversity and women in the fields of pulmonary, critical care, and sleep medicine. More

May 16

  • Revolutionizing Human LongevitySupercomputers can analyze enormous amounts of data, and use algorithms to predict your life span and the development of diseases in their genesis. This heady update on technology and the status of precision medicine was delivered by J. Craig Venter, PhD, a leader in genome research, during Saturday's Opening Ceremony, More
  • New Technologies to Check OutThe ATS Exhibit Hall is the venue for getting a first look at the latest technologies available for pulmonary, critical care, and sleep medicine professionals. More
  • Keynote Series: Lung Cancer, PAH, and CTEPHThe ATS Keynote Series continues Monday with discussions about lung cancer detection and prevention, and the evolution of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). More
  • Presidents’ Terms Define ProgressATS President Atul Malhotra, MD, reviewed accomplishments while President-Elect David Gozal, MD, outlined his goals during the Opening Ceremony. More
  • Q&A: ATS President Atul Malhotra, MDQ: What have you found most gratifying during your term as president? A: My focus has been on the next generation, and attracting and attaining top talent in the field. More
  • ATS PAR Empowers PatientsPatients and families are central to the mission of the American Thoracic Society. With a theme of empowering patients with technology, experts in pulmonary, critical care, and sleep medicine shared their insights with patients and family members during the Public Advisory Roundtable Meet-the-Experts Forum on Saturday. More
  • Donors Honor Next Generation of InvestigatorsWith an assortment of hors d'oeuvres, music, and dancing the ATS Foundation kicked off its Eighth Annual Research Program Benefit on Saturday evening. More
  • Changes for Monitoring Patients on VentilatorsLevels of ventilator-assisted pneumonia (VAP) have declined but remain a concern, so the Centers for Disease Control and Prevention has proposed changes to the monitoring of complications from ventilators. The changes focus on ventilator-associated complications (VAC), which may affect VAP. More
  • Four Honored for Scientific AccomplishmentsCelebrate the achievements of four expert researchers for their outstanding scientific contributions in basic or clinical research that enhances the understanding, prevention, and treatment of lung disease during the Recognition Awards for Scientific Accomplishments. More
  • Programs Bolster Early Career ProfessionalsThe ATS Fellows Track Symposium, Resident Boot Camp, and Student Scholars Program have become so popular with early career professionals that attendance has increased each year. More
  • Practice Essentials for Non-IPF ILDThe broad category of interstitial lung disease (ILD) comprises idiopathic and non-idiopathic pulmonary fibrosis (IPF), with the latter making up most of the cases. Yet, determining which form of non-IPF a patient has is challenging for physicians because there are more than 200 non-IPF ILDs. More
  • ATS Foundation Thanks 2015 Contributors The ATS Foundation is pleased to recognize our generous donors who contributed to the Foundation's Funds for the Future Annual Campaign from Jan 1, 2015, to Dec 31, 2015. More

May 15